


|
State Laws and Their Impact on MRO Practice in the Non-Federal Testing
Arena (author: Josephine Kenney, JD)
An Overview of how State statutes, regulations and relevant case law effect the role and
functions of a medical review officer (MRO) in workplace drug and alcohol testing
programs, with specific emphasis on programs that are not mandated by Federal rules.
In addition to discussion of the MRO role in the review and interpretation of test results,
the monograph provides information useful to MROs who also provide policy
consultation to employers, offer specimen collection and alcohol testing services, and
engage in other drug-free workplace program activities.
Scheduled Availability Date: May 1, 2010 pre-order at a discount price
|
|
Alcohol testing in workplace and post-treatment monitoring programs;
methods (urine, blood, breath, saliva); alcohol biomarkers (EtG/EtS, PETH,
etc.) and interpretation of results (authors: Donna Smith, PhD and David Kuntz, PhD)
A comprehensive discussion of the methods and technology used in alcohol testing in
workplace, treatment, and post-rehabilitation monitoring programs. The monograph
addresses the pros and cons of various alcohol testing methods based on program
objectives and purpose; new technology for detecting alcohol biomarkers (EtG/EtS,
PETH, etc.) and its use in workplace and post-treatment monitoring programs; and the
interpretation of alcohol test results.
Scheduled Availability Date: August 1, 2010
|
|
Non-Federal MRO Drug and Alcohol Test Verifications: Difficult and
Complex Case Studies (authors: Natalie Hartenbaum, MD and Karl Auerbach, MD)
A monograph for the experienced MRO presenting drug and alcohol tests results that
involve complex and multiple factors in the review, interpretation and final determination.
Using a case study approach, the monograph discusses various approaches, decision
making and justification used by MROs in reviewing, interpreting and reporting test
results for non-Federal programs. Special emphases will include cases involving
benzodiazepines, synthetic opioids, steroids, and urine alcohol biomarkers (EtG/EtS)
Scheduled Availability Date: November 1, 2010
|

